【博腾双载荷ADC IND成功交付】据博腾股份消息，近期，博腾一站式蛋白与偶联药物CDMO平台成功完成双载荷ADC工艺开发与GMP IND临床样品全流程交付，涵盖Payload-Linker、抗体、ADC研发、生产等核心环节，完整落地从工艺研发到注册样品放行全流程服务。此次双载荷ADC IND临床样品的成功交付，充分验证了博腾平台在复杂偶联药物领域的技术实力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.